Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals Shareholders Equity (Quarterly) : 1.013B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.013B |
| December 31, 2025 | 954.27M |
| September 30, 2025 | 920.24M |
| June 30, 2025 | 856.03M |
| March 31, 2025 | 794.28M |
| December 31, 2024 | 727.63M |
| September 30, 2024 | 660.94M |
| June 30, 2024 | 608.66M |
| March 31, 2024 | 561.41M |
| December 31, 2023 | 387.88M |
| September 30, 2023 | 348.55M |
| June 30, 2023 | 375.29M |
| March 31, 2023 | 333.66M |
| December 31, 2022 | 300.42M |
| September 30, 2022 | 270.04M |
| June 30, 2022 | 241.09M |
| March 31, 2022 | 220.22M |
| December 31, 2021 | 206.83M |
| September 30, 2021 | 198.66M |
| June 30, 2021 | 188.94M |
| March 31, 2021 | 178.65M |
| December 31, 2020 | 169.60M |
| September 30, 2020 | 156.63M |
| June 30, 2020 | 111.20M |
| March 31, 2020 | 99.68M |
| Date | Value |
|---|---|
| December 31, 2019 | 87.63M |
| September 30, 2019 | 77.98M |
| June 30, 2019 | 63.28M |
| March 31, 2019 | 51.18M |
| December 31, 2018 | 50.78M |
| September 30, 2018 | 64.08M |
| June 30, 2018 | 71.06M |
| March 31, 2018 | 76.25M |
| December 31, 2017 | 80.96M |
| September 30, 2017 | 31.73M |
| June 30, 2017 | 33.97M |
| March 31, 2017 | 35.10M |
| December 31, 2016 | 39.31M |
| September 30, 2016 | 42.90M |
| June 30, 2016 | 46.33M |
| March 31, 2016 | 50.54M |
| December 31, 2015 | 55.48M |
| September 30, 2015 | 60.65M |
| June 30, 2015 | 62.79M |
| March 31, 2015 | 66.62M |
| December 31, 2014 | 35.24M |
| September 30, 2014 | 36.62M |
| June 30, 2014 | 41.19M |
| March 31, 2014 | 17.64M |
| December 31, 2013 | 21.39M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 4.371M |
| Indivior Pharmaceuticals, Inc. | -208.00M |
| Exelixis, Inc. | 1.844B |
| United Therapeutics Corp. | 6.400B |
| Krystal Biotech, Inc. | 1.359B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.148B |
| Total Liabilities (Quarterly) | 134.91M |
| Debt to Equity Ratio | 0.0026 |
| Current Ratio | 7.103 |
| Net Debt Paydown Yield | 0.00% |